Your browser doesn't support javascript.
loading
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.
Yutani, Shigeru; Shirahama, Takahisa; Muroya, Daisuke; Matsueda, Satoko; Yamaguchi, Rin; Morita, Michi; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Itoh, Kyogo.
Afiliación
  • Yutani S; Cancer Vaccine Center, Kurume University, Kurume, Japan.
  • Shirahama T; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Muroya D; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Matsueda S; Cancer Vaccine Center, Kurume University, Kurume, Japan.
  • Yamaguchi R; Division of Pathology, Medical Center of Kurume University, Kurume, Japan.
  • Morita M; Division of Pathology, Medical Center of Kurume University, Kurume, Japan.
  • Shichijo S; Cancer Vaccine Center, Kurume University, Kurume, Japan.
  • Yamada A; Cancer Vaccine Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan.
  • Sasada T; Cancer Vaccine Center, Kanagawa Cancer Center, Yokohama, Japan.
  • Itoh K; Cancer Vaccine Center, Kurume University, Kurume, Japan.
Cancer Sci ; 108(9): 1732-1738, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28622427

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Vacunas contra el Cáncer / Neoplasias Hepáticas Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Vacunas contra el Cáncer / Neoplasias Hepáticas Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2017 Tipo del documento: Article País de afiliación: Japón